Course Description
Join the Conversation: Real Cases, Real Challenges, Real Learning
Step into a dynamic 30 minutes of facilitated discussion where substance use disorder (SUD) cases take center stage—especially the ones where evidence is limited, cannot be uniformly applied, or may not exist. Collaborate with your peers to unpack complex scenarios, debate treatment paths, and problem-solve solutions.
AAPP members can register once for this complimentary series and attend as many of the webinars as you like!
- Once registered, you will have access to each session’s case presentation and the session recordings, which will be available afterward.
- All materials can be found in the Course Materials section below.
- Registered attendees will receive an email reminder on the day of the session, which begin at 2:00 PM Central.
- ACPE credit is not available for SUD Scoop.
Upcoming Webinars:
November 4, 2026 | Designer Benzodiazepine Withdrawal
Case Overview: A patient with multiple psychiatric comorbidities and about to undergo benzodiazepine (benzo) withdrawal presented to the emergency department where designer benzo use was incidentally discovered. Given his complex psychiatric background and increasing CIWA trend, phenobarbital and diazepam were selected in-patient to target his benzo withdrawal while minimizing seizure risk. The patient subsequently transitioned to clonazepam and hydroxyzine with good tolerability, however declined residential treatment for follow-up. This case highlights the need for further research into the mechanisms of designer benzodiazepines and the development of novel treatment strategies.
Moderator: Michelle Geier, PharmD, APh, MPH, BCPP, FAAPP
Case Presenters:
Sierra Aguilar | PharmD Candidate 2027 APPE Student at South Texas Veterans Health Care System San Antonio, TX Sierra Aguilar is currently completing her PharmD. at The University of Texas at Austin in Austin, Texas. During pharmacy school, she engaged in research focused on drug interactions in geriatric populations, developing student-led community engagement initiatives, and was recognized with the AAPP Foundation Student Registration Grant. She served as the Vice President of her AAPP Student Chapter at UT Austin and gained additional SUD experience by rotating with Dr. Williams at the VA. | |
Raeschell "Shelly" Williams, PharmD, MPH, BCPS, BCPP
Dr. Williams is a graduate of the University of Virginia where she earned her BA in Psychology. She then relocated to Kentucky where she earned her PharmD and MPH degrees from the University of Kentucky Colleges of Pharmacy and Public Health, respectively. She then moved to San Antonio, TX, where she completed her PGY1 Pharmacy Practice and PGY2 Psychiatric Pharmacy residencies at the South Texas Veterans Health Care System. She currently works as a clinical pharmacist practitioner (CPP) at the South Texas Veterans Health Care System at the Domiciliary Residential Rehabilitation Treatment Program (DRRTP), focusing on medication management for substance use disorders and mental health conditions. She is Board Certified in Pharmacotherapy and Psychiatric Pharmacy and has experience in substances of misuse through her work in the Clinical Pharmacy Practice Office (CPPO) Substance Use Disorder Subject Matter Expert Workgroup, AAPP SUD Committee, along with her current practice role. |
December 9, 2026
Case Overview: Details to be released closer to the date!
Moderator: Dongmi Kim, BCPP, BCPS, PharmD
Case Presenter:
Mei T. Liu, PharmD, BCPP Clinical Associate Professor, Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey |
February 10, 2027
Case Overview: Details to be released closer to the date!
Moderator: Lauren Wier, PharmD, BCPP
Case Presenters:
Brenna Dooley, PharmD PGY-2 Ambulatory Care Resident at UC Davis Health System | |
Rebecca (Becky) Hoss, PharmD, BCPP Clinical SUD/Pain Pharmacist at UC Davis Health System |
March 10, 2027
Case Overview: Details to be released closer to the date!
Moderator: Katie Chamberlain, BCPP, BCPS, PharmD
Case Presenter:
Amber R. Tran, PharmD, BCPP Clinical Pharmacist - Psychiatry at John Peter Smith (JPS) Health Network |
May 12, 2027
Case Overview: Details to be released closer to the date!
Moderator: Michelle Colvard, BCPP, PharmD, FAAPP
Case Presenters:
Tess Mcgill, PharmD PGY1 Pharmacy Resident, Department of Veterans Affairs | |
Annette Percy, PharmD, BCPP
|
June 9, 2027
Case Overview: Details to be released closer to the date!
Moderator: Zoe Karavolis, PharmD, MPH, BCPP, CPH
Case Presenters:
Ashley Maister, BS, PharmD, BCPP Clinical Pharmacy Practitioner, Psychiatry, at Corporal Michael J Crescenz VA Medical Center | |
Lauren Shiplett, PharmD Pain Management/Substance Use Disorder Clinical Pharmacy Practitioner at Wilkes-Barre Veterans Affairs Medical Center |
Webinar Series Dates (Add to Calendar)
Check back to add these events to your calendar!
Disclosure
The SUD Scoop Series is an unaccredited member-driven initiative to facilitate dialogue among psychiatric pharmacy professionals. While presenters are encouraged to disclose any conflicts and to use the best evidence available, the presentations are not peer reviewed and attendees should accordingly verify details prior to making significant practice changes.
Continuing Education Credit and Disclosures
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. The faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Copyright Statement, Terms of Use, and Policies
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Privacy Policy. AAPP's Terms of Use and other policies on education programs, resources, toolkits, and other web based content/offerings are available here.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.